Hib-DTP vaccine (Easyfour) - Panacea Biotec

Drug Profile

Hib-DTP vaccine (Easyfour) - Panacea Biotec

Alternative Names: DTwP-Hib vaccine - Panacea Biotec; Easy-4; Easyfour; Easyfour - Chiron Panacea; Easyfour-TT; Quadrivalent vaccine - Panacea Biotec

Latest Information Update: 21 Feb 2014

Price : $50

At a glance

  • Originator Panacea Biotec
  • Class Haemophilus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Diphtheria; Haemophilus infections; Pertussis; Tetanus

Most Recent Events

  • 01 Jan 2008 Launched for Diphtheria, Tetanus, Pertussis and Haemophilus infections (prevention) in India (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top